Financial Snapshot

Revenue
$0.00
TTM
Gross Margin
Net Earnings
-$3.916M
TTM
Current Assets
Q4 2024
Current Liabilities
Q4 2024
Current Ratio
605.18%
Q4 2024
Total Assets
Q4 2024
Total Liabilities
Q4 2024
Book Value
$2.440M
Q4 2024
Cash
Q4 2024
P/E
-0.9058
Nov 29, 2024 EST
Free Cash Flow

Revenues

Revenues

Revenue YoY Change

Revenues

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993
Revenue $184.0K $557.0K $1.526M $4.838M $2.610M $6.618M $215.0K $15.07M $1.671M $3.646M $10.48M $7.117M $4.068M $10.09M $80.00K $70.00K $20.00K $30.00K $90.00K $30.00K $90.00K $2.890M $4.570M $1.880M $340.0K $0.00 $17.50M $260.0K $140.0K $0.00 $0.00
YoY Change -66.97% -63.5% -68.46% 85.36% -60.56% 2978.14% -98.57% 801.56% -54.17% -65.21% 47.27% 74.95% -59.68% 12512.5% 14.29% 250.0% -33.33% -66.67% 200.0% -66.67% -96.89% -36.76% 143.09% 452.94% -100.0% 6630.77% 85.71%

Expenses

Cost Of Revenues

Gross Profit

Gross Profit Margin

Gross Profit

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993
Revenue $184.0K $557.0K $1.526M $4.838M $2.610M $6.618M $215.0K $15.07M $1.671M $3.646M $10.48M $7.117M $4.068M $10.09M $80.00K $70.00K $20.00K $30.00K $90.00K $30.00K $90.00K $2.890M $4.570M $1.880M $340.0K $0.00 $17.50M $260.0K $140.0K $0.00 $0.00
Cost Of Revenue $199.0K $472.0K $0.00 $538.0K $0.00 $0.00
Gross Profit $557.0K $1.327M $4.366M $2.610M $6.080M $215.0K $15.07M
Gross Profit Margin 100.0% 86.96% 90.24% 100.0% 91.87% 100.0% 100.0%

Selling, General & Admin Expense

Research & Development

Depreciation, Depletion & Amortization

SGA Expense to Gross Profit Ratio

R&D To Gross Profit Ratio

DDA To Gross Profit Ratio

Operating Expenses Total

Operating Profits/Loss

Operational Expenses

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993
Selling, General & Admin $5.548M $6.034M $4.989M $5.800M $5.400M $6.866M $5.069M $4.596M $3.760M $3.050M $3.060M $4.880M $3.370M $3.260M $3.440M $9.760M $6.210M $4.860M $5.370M $5.240M $5.110M $5.080M $5.380M $4.070M $2.790M $3.710M $6.510M $5.260M $3.660M $2.500M $350.0K
YoY Change -8.05% 20.95% -13.98% 7.41% -21.35% 35.45% 10.29% 22.23% 23.28% -0.33% -37.3% 44.81% 3.37% -5.23% -64.75% 57.17% 27.78% -9.5% 2.48% 2.54% 0.59% -5.58% 32.19% 45.88% -24.8% -43.01% 23.76% 43.72% 46.4% 614.29%
% of Gross Profit 1083.3% 375.96% 132.84% 206.9% 112.93% 2357.67% 30.51%
Research & Development $1.913M $4.758M $5.692M $5.916M $5.080M $7.478M $9.648M $6.126M $4.675M $4.075M $8.309M $10.61M $11.21M $12.86M $2.460M $16.24M $12.24M $11.62M $17.77M $21.17M $26.15M $29.82M $23.34M $21.71M $9.570M $7.810M $18.81M $5.570M $5.890M $10.60M $5.440M
YoY Change -59.79% -16.41% -3.79% 16.46% -32.07% -22.49% 57.49% 31.04% 14.72% -50.96% -21.69% -5.32% -12.86% 422.76% -84.85% 32.68% 5.34% -34.61% -16.06% -19.04% -12.31% 27.76% 7.51% 126.85% 22.54% -58.48% 237.7% -5.43% -44.43% 94.85%
% of Gross Profit 854.22% 428.94% 135.5% 194.64% 122.99% 4487.44% 40.66%
Depreciation & Amortization $5.000K $112.0K $196.0K $221.0K $292.0K $240.0K $380.0K $417.0K $377.0K $358.0K $353.0K $107.0K $17.00K $32.00K $90.00K $170.0K $210.0K $290.0K $390.0K $410.0K $470.0K $440.0K $370.0K $270.0K $340.0K $410.0K $120.0K $390.0K $500.0K $330.0K $200.0K $40.00K
YoY Change -95.54% -42.86% -11.31% -24.32% 21.67% -36.84% -8.87% 10.61% 5.31% 1.42% 229.91% 529.41% -46.88% -64.44% -47.06% -19.05% -27.59% -25.64% -4.88% -12.77% 6.82% 18.92% 37.04% -20.59% -17.07% 241.67% -69.23% -22.0% 51.52% 65.0% 400.0%
% of Gross Profit 35.19% 16.65% 6.69% 9.2% 6.25% 193.95% 2.5%
Operating Expenses $4.557M $7.461M $10.79M $5.692M $5.916M $10.49M $14.88M $14.72M $10.72M $8.430M $7.121M $11.37M $15.49M $14.57M $16.12M $5.890M $25.99M $18.46M $16.48M $23.14M $26.41M $31.26M $34.90M $28.72M $25.78M $12.36M $11.52M $25.32M $10.83M $9.550M $13.11M $5.800M
YoY Change -38.92% -30.87% 89.6% -3.79% -43.6% -29.51% 1.12% 37.26% 27.19% 18.38% -37.38% -26.57% 6.26% -9.59% 173.68% -77.34% 40.79% 12.01% -28.78% -12.38% -15.52% -10.43% 21.52% 11.4% 108.58% 7.29% -54.5% 133.8% 13.4% -27.15% 126.03%
Operating Profit -$4.557M -$7.277M -$10.24M -$9.354M -$7.351M -$7.880M -$8.264M -$14.50M $4.343M -$6.759M -$3.475M -$891.0K -$8.370M -$10.51M
YoY Change -37.38% -28.9% 9.42% 27.25% -6.71% -4.65% -43.01% -433.92% -164.26% 94.5% 290.01% -89.35% -20.33%

Interest Expenses

Interest Expenses To Operating Income %

Other Expense/Income

Interest & Other Expense/Income

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993
Interest Expense $1.000K $5.000K $53.00K $1.000K -$769.0K $140.0K -$887.0K -$369.0K $37.00K $0.00 $0.00 -$1.568M -$4.861M -$6.430M -$680.0K -$10.00K $470.0K $650.0K $720.0K $570.0K $670.0K $1.280M $4.220M $6.760M $5.160M $760.0K $850.0K -$150.0K -$2.290M -$2.290M -$100.0K -$150.0K
YoY Change -80.0% -90.57% 5200.0% -100.13% -649.29% -115.78% 140.38% -1097.3% -100.0% -67.74% -24.4% 845.59% 6700.0% -102.13% -27.69% -9.72% 26.32% -14.93% -47.66% -69.67% -37.57% 31.01% 578.95% -10.59% -666.67% -93.45% 0.0% 2190.0% -33.33%
% of Operating Profit 0.85%
Other Income/Expense, Net -$149.0K $1.708M $29.00K $578.0K -$56.00K $20.00K -$759.0K $195.0K $792.0K -$4.520M $1.072M $10.60M -$6.810M -$4.697M -$130.0K -$70.00K $10.00K $140.0K -$10.00K $20.00K -$300.0K $10.00K -$400.0K -$80.00K -$40.00K -$30.00K $70.00K $0.00 $200.0K $190.0K
YoY Change -108.72% 5789.66% -94.98% -1132.14% -380.0% -102.64% -489.23% -75.38% -117.52% -521.64% -89.89% -255.68% 44.99% 3513.08% 85.71% -800.0% -92.86% -1500.0% -150.0% -106.67% -3100.0% -102.5% 400.0% 100.0% 33.33% -142.86% 5.26%

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

Net Profits/Loss YoY Change

Basic EPS

Net Income To Revenue Ratio

Pretax & Net Income

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993
Pretax Income -$5.569M -$10.21M -$8.776M -$7.410M -$7.490M -$9.020M -$14.31M $5.140M -$11.28M -$2.400M $9.710M -$15.18M -$15.20M -$6.830M -$5.890M -$25.43M -$17.65M -$15.74M -$22.46M -$26.00M -$29.89M -$28.18M -$17.46M -$18.79M -$11.30M -$10.61M $590.0K -$12.87M -$11.69M -$13.00M -$5.760M
YoY Change -45.43% 16.29% 18.43% -1.07% -16.96% -36.97% -378.4% -145.57% 370.0% -124.72% -163.97% -0.13% 122.55% 15.96% -76.84% 44.08% 12.13% -29.92% -13.62% -13.01% 6.07% 61.4% -7.08% 66.28% 6.5% -1898.31% -104.58% 10.09% -10.08% 125.69%
Income Tax $1.000K $1.000K -$4.000K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -$1.000K $1.000K $1.000K $5.000K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
% Of Pretax Income 0.0% 0.01% 0.0%
Net Earnings -$4.706M -$5.569M -$10.21M -$8.776M -$18.24M -$16.46M -$9.023M -$14.31M $5.135M -$11.28M -$2.403M $9.711M -$15.18M -$15.20M -$6.830M -$5.890M -$25.43M -$17.65M -$15.74M -$22.46M -$26.00M -$29.89M -$28.18M -$17.46M -$18.79M -$11.30M -$10.61M $590.0K -$12.86M -$11.69M -$12.98M -$5.760M
YoY Change -15.5% -45.43% 16.29% -51.89% 10.83% 82.42% -36.93% -378.62% -145.53% 369.37% -124.75% -163.97% -0.15% 122.59% 15.96% -76.84% 44.08% 12.13% -29.92% -13.62% -13.01% 6.07% 61.4% -7.08% 66.28% 6.5% -1898.31% -104.59% 10.01% -9.94% 125.35%
Net Earnings / Revenue -3026.63% -1832.32% -575.1% -377.06% -630.65% -136.34% -6654.42% 34.09% -674.99% -65.91% 92.65% -213.29% -373.72% -67.69% -7362.5% -36328.57% -88250.0% -52466.67% -24955.56% -86666.67% -33211.11% -975.09% -382.06% -999.47% -3323.53% 3.37% -4946.15% -8350.0%
Basic Earnings Per Share -$5.23 -$7.41 -$15.19 -$0.78 -$4.05 $1.49 -$0.56 -$0.14 $0.65 -$0.23 -$0.26
Diluted Earnings Per Share -$5.23 -$7.41 -$0.76 -$902.0K -$4.838M -$21.38M -$0.79 -$4.22 $1.20 -$0.56 -$0.20 $0.53 -$0.23 -$0.28 -$113.8M -$98.17M -$423.8M -$441.2M -$393.5M -$748.7M -$866.7M -$996.3M -$939.3M -$582.0M -$626.3M -$565.0M -$1.061B $59.00M -$1.286B -$1.169B -$5.581B -$2.734B

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

Cash To Operating Expenses Ratio

Inventory

Receivables

Total Short-Term Assets

Property, Plant And Equipment

Long-Term Investments

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

Long Term Debt Due

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

Assets & Liabilities

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993
Cash & Short-Term Investments $6.760M $2.937M $6.037M $5.400M $5.200M $9.300M $7.500M $14.00M $7.900M $15.50M $11.80M $18.10M $5.400M $3.200M $3.300M $4.700M $30.00M $13.70M $17.40M $36.30M $46.60M $73.50M $105.1M $117.5M $46.50M $11.70M $24.90M $14.40M $900.0K $1.300M $11.60M
YoY Change 130.17% -51.35% 11.8% 3.85% -44.09% 24.0% -46.43% 77.22% -49.03% 31.36% -34.81% 235.19% 68.75% -3.03% -29.79% -84.33% 118.98% -21.26% -52.07% -22.1% -36.6% -30.07% -10.55% 152.69% 297.44% -53.01% 72.92% 1500.0% -30.77% -88.79%
Cash & Equivalents $6.760M $2.937M
Short-Term Investments $0.00 $4.400M $4.100M $8.200M $30.90M $39.70M $66.30M $99.30M $97.20M $0.00 $0.00 $500.0K $13.00M $0.00 $0.00 $8.900M
Other Short-Term Assets $212.0K $524.0K $787.0K $700.0K $1.100M $900.0K $800.0K $200.0K $200.0K $100.0K $200.0K $700.0K $800.0K $300.0K $300.0K $700.0K $400.0K $500.0K $1.200M $1.100M $1.200M $900.0K $400.0K $200.0K $300.0K $100.0K $100.0K $200.0K $0.00 $100.0K $300.0K
YoY Change -59.54% -33.42% 12.43% -36.36% 22.22% 12.5% 300.0% 0.0% 100.0% -50.0% -71.43% -12.5% 166.67% 0.0% -57.14% 75.0% -20.0% -58.33% 9.09% -8.33% 33.33% 125.0% 100.0% -33.33% 200.0% 0.0% -50.0% -100.0% -66.67%
Inventory $0.00 $106.0K $293.0K $300.0K $1.000M $1.300M
Prepaid Expenses
Receivables $46.00K $36.00K $112.0K $900.0K $1.000M $1.800M $100.0K $3.600M $4.200M $4.000M $4.800M $4.600M $3.700M $1.200M $100.0K $0.00 $100.0K $300.0K $500.0K $100.0K
Other Receivables $1.000M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Total Short-Term Assets $8.018M $3.603M $7.229M $7.300M $8.300M $13.30M $8.300M $17.80M $12.20M $19.60M $16.80M $23.40M $10.00M $4.700M $3.600M $5.400M $30.50M $14.20M $18.60M $37.40M $47.90M $74.60M $106.0M $117.8M $46.90M $11.80M $25.30M $14.70M $1.000M $1.500M $11.90M
YoY Change 122.54% -50.16% -0.97% -12.05% -37.59% 60.24% -53.37% 45.9% -37.76% 16.67% -28.21% 134.0% 112.77% 30.56% -33.33% -82.3% 114.79% -23.66% -50.27% -21.92% -35.79% -29.62% -10.02% 151.17% 297.46% -53.36% 72.11% 1370.0% -33.33% -87.39%
Property, Plant & Equipment $68.00K $407.0K $717.0K $800.0K $1.200M $800.0K $600.0K $800.0K $1.000M $1.300M $1.600M $1.400M $300.0K $100.0K $100.0K $300.0K $400.0K $500.0K $800.0K $1.000M $800.0K $1.000M $600.0K $600.0K $400.0K $400.0K $300.0K $800.0K $800.0K $1.200M $600.0K
YoY Change -83.29% -43.24% -10.38% -33.33% 50.0% 33.33% -25.0% -20.0% -23.08% -18.75% 14.29% 366.67% 200.0% 0.0% -66.67% -25.0% -20.0% -37.5% -20.0% 25.0% -20.0% 66.67% 0.0% 50.0% 0.0% 33.33% -62.5% 0.0% -33.33% 100.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00 $200.0K $200.0K $200.0K $300.0K $300.0K $600.0K $0.00 $0.00 $600.0K $1.600M $0.00 $0.00
YoY Change -100.0% 0.0% 0.0% -33.33% 0.0% -50.0% -100.0% -62.5%
Other Assets $0.00 $48.00K $48.00K $0.00 $200.0K $200.0K $0.00 $0.00 $0.00 $300.0K $1.200M $500.0K $300.0K
YoY Change -100.0% 0.0% -100.0% 0.0% -100.0% -75.0% 140.0% 66.67%
Total Long-Term Assets $68.00K $455.0K $765.0K $800.0K $1.200M $800.0K $600.0K $900.0K $1.100M $1.300M $1.600M $1.400M $200.0K $100.0K $100.0K $300.0K $300.0K $800.0K $1.100M $1.200M $1.100M $1.300M $1.100M $600.0K $500.0K $400.0K $300.0K $1.700M $3.700M $1.600M $900.0K
YoY Change -85.05% -40.52% -4.38% -33.33% 50.0% 33.33% -33.33% -18.18% -15.38% -18.75% 14.29% 600.0% 100.0% 0.0% -66.67% 0.0% -62.5% -27.27% -8.33% 9.09% -15.38% 18.18% 83.33% 20.0% 25.0% 33.33% -82.35% -54.05% 131.25% 77.78%
Total Assets $8.086M $4.058M $7.994M $8.100M $9.500M $14.10M $8.900M $18.70M $13.30M $20.90M $18.40M $24.80M $10.20M $4.800M $3.700M $5.700M $30.80M $15.00M $19.70M $38.60M $49.00M $75.90M $107.1M $118.4M $47.40M $12.20M $25.60M $16.40M $4.700M $3.100M $12.80M
YoY Change
Accounts Payable $348.0K $695.0K $795.0K $1.300M $1.400M $1.500M $800.0K $3.000M $4.200M $4.400M $5.100M $3.800M $4.800M $2.500M $300.0K $500.0K $600.0K $600.0K $500.0K $700.0K $1.500M $1.900M $900.0K $1.300M $800.0K $400.0K $800.0K $600.0K $700.0K $900.0K $1.000M
YoY Change -49.93% -12.58% -38.85% -7.14% -6.67% 87.5% -73.33% -28.57% -4.55% -13.73% 34.21% -20.83% 92.0% 733.33% -40.0% -16.67% 0.0% 20.0% -28.57% -53.33% -21.05% 111.11% -30.77% 62.5% 100.0% -50.0% 33.33% -14.29% -22.22% -10.0%
Accrued Expenses $584.0K $1.610M $435.0K $700.0K $1.400M $1.100M $600.0K $1.800M $700.0K $600.0K $400.0K $800.0K $300.0K $1.100M $700.0K $2.100M $3.700M $2.800M $2.600M $3.000M $1.800M $2.000M $2.900M $1.200M $1.000M $1.200M $900.0K $1.100M $1.500M $1.400M $600.0K
YoY Change -63.73% 270.11% -37.86% -50.0% 27.27% 83.33% -66.67% 157.14% 16.67% 50.0% -50.0% 166.67% -72.73% 57.14% -66.67% -43.24% 32.14% 7.69% -13.33% 66.67% -10.0% -31.03% 141.67% 20.0% -16.67% 33.33% -18.18% -26.67% 7.14% 133.33%
Deferred Revenue
YoY Change
Short-Term Debt $500.0K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $4.300M $1.200M $1.200M
YoY Change -100.0% 258.33% 0.0%
Long-Term Debt Due $0.00 $300.0K $0.00 $500.0K $3.000M $0.00 $2.500M $0.00 $1.900M $500.0K $0.00 $0.00 $800.0K $700.0K $200.0K $0.00
YoY Change -100.0% -100.0% -83.33% -100.0% -100.0% 280.0% -100.0% 14.29% 250.0%
Total Short-Term Liabilities $1.444M $2.630M $2.669M $4.200M $3.600M $3.500M $4.500M $4.900M $4.900M $6.700M $10.80M $21.40M $5.100M $5.400M $1.500M $2.600M $4.300M $3.400M $3.100M $3.700M $3.300M $3.900M $5.800M $2.500M $1.800M $1.600M $1.700M $2.500M $7.300M $3.700M $2.800M
YoY Change -45.1% -1.46% -36.45% 16.67% 2.86% -22.22% -8.16% 0.0% -26.87% -37.96% -49.53% 319.61% -5.56% 260.0% -42.31% -39.53% 26.47% 9.68% -16.22% 12.12% -15.38% -32.76% 132.0% 38.89% 12.5% -5.88% -32.0% -65.75% 97.3% 32.14%
Long-Term Debt $0.00 $0.00 $0.00 $300.0K $4.000M $3.800M $3.600M $0.00 $0.00 $0.00 $0.00 $9.400M $12.30M $5.400M $2.400M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $1.200M $2.000M $1.000M $0.00
YoY Change -100.0% -92.5% 5.26% 5.56% -100.0% -23.58% 127.78% 125.0% -100.0% -40.0% 100.0%
Other Long-Term Liabilities $0.00 $65.00K $187.0K $0.00 $500.0K $0.00 $0.00 $600.0K $1.400M $5.600M $1.800M $17.20M $12.90M $0.00 $0.00 $5.500M $0.00 $0.00 $0.00 $0.00
YoY Change -100.0% -65.24% -100.0% -100.0% -57.14% -75.0% 211.11% -89.53% 33.33% -100.0%
Total Long-Term Liabilities $0.00 $65.00K $187.0K $300.0K $4.500M $3.800M $3.600M $600.0K $1.400M $5.600M $1.800M $26.60M $25.20M $5.400M $2.400M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $5.500M $1.200M $2.000M $1.000M $0.00
YoY Change -100.0% -65.24% -37.67% -93.33% 18.42% 5.56% 500.0% -57.14% -75.0% 211.11% -93.23% 5.56% 366.67% 125.0% -100.0% 358.33% -40.0% 100.0%
Total Liabilities $1.444M $2.695M $2.856M $4.600M $8.100M $7.300M $8.000M $5.500M $6.300M $12.20M $12.70M $48.00M $30.30M $10.80M $5.200M $3.900M $5.500M $4.600M $4.400M $4.900M $4.600M $5.200M $7.000M $3.700M $3.100M $2.800M $8.400M $5.000M $10.60M $5.900M $2.800M
YoY Change -46.42% -5.64% -37.91% -43.21% 10.96% -8.75% 45.45% -12.7% -48.36% -3.94% -73.54% 58.42% 180.56% 107.69% 33.33% -29.09% 19.57% 4.55% -10.2% 6.52% -11.54% -25.71% 89.19% 19.35% 10.71% -66.67% 68.0% -52.83% 79.66% 110.71%

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

Preferred Stock

No data

Treasury Stock Shares

No data

Stock Issuance & Repurchase

Ownership Data

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993
Basic Shares Outstanding 899.0K shares 752.0K shares 672.0K shares 9.730M 3.773M 22.96M 11.96M 3.534M 3.457M 20.05M shares 17.06M shares 14.93M shares 66.51M shares 59.32M shares
Diluted Shares Outstanding 899.0K shares 752.0K shares 672.0K shares 9.730M 3.773M 11.96M 3.538M 3.577M 20.05M shares 17.06M shares 15.03M shares 66.51M shares 60.39M shares
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Book Value

Free Cash Flow

Free Cash Flow YoY

Free Cash Flow Margin

Dividends

Dividends

No data

Stock Price

Market Cap: $3.5472 Million

About TITAN PHARMACEUTICALS INC

Titan Pharmaceuticals, Inc. engages in the development of therapeutics for the treatment of chronic diseases utilizing its long-term, continuous drug delivery platform, proNeura. The company is headquartered in San Francisco, California and currently employs 4 full-time employees. The firm is focused on developing therapeutics utilizing the proprietary long-term drug delivery platform, ProNeura, for the treatment of select chronic diseases. ProNeura offers continuous drug delivery and consists of a small, semi-rigid, flexible implant made from a mixture of ethylene-vinyl acetate (EVA) and a drug substance. The resulting product is a solid matrix implant that is placed subdermally, normally in the inside part of the upper arm, in a brief procedure using a local anesthetic and is removed in a similar manner at the end of the treatment period. Its product pipeline includes Kappa Opioid Receptor Agonist (TP-2021) Implant, which is used for the treatment of moderate-to-severe chronic pruritus. Its product development programs are in non-clinical stages of development.

Industry: Biological Products, (No Diagnostic Substances) Peers: Ampio Pharmaceuticals, Inc. TREX WIND-DOWN, INC. Avenir Wellness Solutions, Inc. Eloxx Pharmaceuticals, Inc. Evofem Biosciences, Inc. JOHNSON & JOHNSON KALA BIO, Inc. MJ Holdings, Inc. OTONOMY, INC.